Balance Sheet Breakdown: Biolife Solutions Inc (BLFS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

After finishing at $24.20 in the prior trading day, Biolife Solutions Inc (NASDAQ: BLFS) closed at $21.95, down -9.30%. In other words, the price has decreased by -$9.30 from its previous closing price. On the day, 1.21 million shares were traded.

Ratios:

Our goal is to gain a better understanding of BLFS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 200.50. For the most recent quarter (mrq), Quick Ratio is recorded 3.66 and its Current Ratio is at 4.54. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 30, 2024, initiated with a Buy rating and assigned the stock a target price of $29.

On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $22.

On July 11, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $29.Craig Hallum initiated its Buy rating on July 11, 2023, with a $29 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 09 ’25 when Wichterman Troy sold 932 shares for $20.11 per share. The transaction valued at 18,743 led to the insider holds 188,310 shares of the business.

Mathew Aby J. sold 569 shares of BLFS for $11,443 on Apr 09 ’25. The EVP & Chief Scientific Officer now owns 309,007 shares after completing the transaction at $20.11 per share. On Apr 09 ’25, another insider, Aebersold Sarah, who serves as the Chief Human Resources Officer of the company, sold 210 shares for $20.11 each. As a result, the insider received 4,223 and left with 79,884 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 9.20 while its Price-to-Book (P/B) ratio in mrq is 2.95.

Stock Price History:

Over the past 52 weeks, BLFS has reached a high of $29.55, while it has fallen to a 52-week low of $17.15. The 50-Day Moving Average of the stock is -9.05%, while the 200-Day Moving Average is calculated to be -11.99%.

Shares Statistics:

A total of 46.91M shares are outstanding, with a floating share count of 45.58M. Insiders hold about 4.05% of the company’s shares, while institutions hold 99.71% stake in the company.

Most Popular